Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of PXD101 in Advanced Multiple Myeloma
2004-002054-55Phase 2Completed
- Sponsor
- TopoTarget
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of belinostat in multiple myeloma (MM) (2 arms), sponsored by TopoTarget. Primary endpoint: Efficacy (response rate). Started Sep 2004; status: completed.
02
Drugs
belinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2004-002054-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002054-55.